References
1. Dahlin DC. Bone Tumors: General Aspects and Data on 6,221 Cases 1978. 3rd edth ed. Springfield, IL: Charles C Thomas;
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA cancer J Clin 2002. 5223–47.
3. Frassica FJ, Gitelis S, Sim FH. Metastatic bone disease: General principles, pathophysiology, evaluation, and biopsy. Instr Course Lect 1992. 41293–300.
4. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin: A prospective study of a diagnotic strategy. J bone Joint Surg Am 1993. 751276–1281.
5. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889. 1571–573.
6. Ewing J, ed. Metastasis, in Neoplastic Diseases: A Treatise on Tumor 1928. 3rd edth ed. Philadelphia: WB Saunders; 77–89.
7. Canale ST. Campbell's operative orthopaedics 2003. 10th edth ed. Mosby: 848.
8. Clohisy DR, Palkert D, Ramnaraine ML, Pekurovsky I, Oursler MJ. Human breast cancer induces osteoclast activation and increases the number of osteoclast at sites of tumor osteolysis. J Orthop Res 1996. 14396–402.
9. Beals RK, Lawton GD, Snell WE. Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 1971. 281350–1354.
10. Mirels H. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop 1989. 249256–264.
11. Katzer A, Meenen NM, Grabbe F, Reuger JM. Surgery of skeletal metastases. Arch Orthop Trauma Surg 2002. 122251–258.
12. Redmond BJ, Biermann JS, Blasier RB. Interlocking intramedullary nailing of pathological fractures of the shaft of the humerus. J Bone Joint Surg Am 1996. 78891–896.
13. Damron TA, Sim FH, Shives TC, An KN, Rock MG, Pritchard DJ. Intercalary spacers in the treatment of segmentally destructive diaphyseal humeral lesions in disseminated malignancies. Clin Othop 1996. 324233–243.
14. Dijkstra S, Stapert J, Boxma H, Wiggers T. Treatment of pathological fractures of the humeral shaft due to bone metastases: A comparison of intramedullay locking nail and plate osteosynthesis with adjunctive bone cement. Eur J Surg Oncol 1996. 22621–626.
15. Harrington KD. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 1981. 63653–664.
16. Marco RA, Sheth DS, Boland PJ, et al. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am 2000. 82642–651.
17. Vena VE, Hsu J, Rosier RN, O'Keefe RJ. Pelvic reconstruction for severe periacetabular metastatic disease. Clin Orthop 1999. 362171–180.
18. Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease: A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop 1990. 251213–219.
19. Lane JM, Sculco TP, Zolan S. Treatment of pathological fractures of the hip by endoprosthetic replacement. J Bone Joint Surg Am 1980. 62954–959.
20. Papagelopoulos PJ, Galanis EC, Greipp PR, Sim FH. Prosthetic hip replacement for pathologic or impending pathologic fractures in myeloma. Clin Orthop 1997. 341192–205.
21. Behr JT, Dobozi WR, Badrinath K. The treatment of pathologic and impending pathologic fractures of the proximal femur in the elderly. Clin Orthop 1985. 198173–178.
22. Ward WG, Spang J, Howe D, Gordan S. Femoral recon nails for metastatic disease: Indications, technique, and results. Am J Orthop 2000. 29S9. 34–42.
23. Weikert DR, Schwartz HS. Intramedullary nailing for impending pathological subtrochanteric fractures. J Bone Joint Surg Br 1991. 73668–670.
24. Favorito PJ, McGrath BE. Impending or completed pathologic femur fracruters treated with intramedullary hip screws. Orthopedics 2001. 24359–363.
25. Sim FH, Chao EY. Hip salvage by proximal femoral replacement. J Bone Joint Surg Am 1981. 631228–1239.
26. Healey JH, Lane JM. Treatment of pathologic fractures of the distal femur with the Zickel supracondylar nail. Clin Orthop 1990. 250216–220.
27. De Geeter K, Reynders P, Samson I, Broos PL. Metastatic fractures of the tibia. Acta Orthop Belg 2001. 6754–59.
28. Hattrup SJ, Amadio PC, Sim FH, Lombardi RM. Metastatic tumors of the foot and ankle. Foot Ankle 1988. 8243–247.
29. Boland PJ, Lane JM, Sundaresan N. Metastatic disease of the spine. Clin Orthop 1982. 16995–102.
30. Suen KC, Lau LL, Yermakov V. Cancer and old age. An autopsy study of 3,535 patients over 65 years old. Cancer 1974. 331164–1168.
31. Galasko CS, Sylvester BS. Back pain in patients treated for malignant tumours. Clin Oncol 1978. 4273–283.
32. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment. Ann Neurol 1978. 340–51.
33. Weill A, Chiras J, Simon JM, Rose M, Sola-Martinez T, Enkaoua E. Spinal metastases: Indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996. 199241–247.
34. Harrington KD. Metastatic disease of the spine. J Bone Joint Surg Am 1986. 681110–1115.
35. Arcangeli G, Micheli A, Arcangeli F, et al. The responsiveness of bone metastases to radiotherapy: The effect of site, histology and radiation dose on pain relief. Radiolther Oncol 1989. 1495–101.
36. Coleman RE. Management of bone metastases. Oncologist 2000. 5463–470.
37. Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989. 321419–424.
38. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine 2000. 01. 26298–306.